approval
saveMEKINIST (TRAMETINIB) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 239d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 239d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 578d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 592d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 592d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 611d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 7, 2025 · 623d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 623d ago
same company · ±60 days · 6
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 19, 2025
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 19, 2025
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalMar 12, 2025
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalMar 12, 2025
- approvallutetium Lu 177 vipivotide tetraxetan: PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvalMar 28, 2025
comments(0)
5-min edit window · permanent after that